Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK to Invest up to £2.8M in Bioscience Research

Published: Thursday, April 17, 2014
Last Updated: Thursday, April 17, 2014
Bookmark and Share
The investment in collaborative feasibility studies aims to stimulate innovation across four technology areas that will enable and underpin UK growth.

The Technology Strategy Board, Invest Northern Ireland (Invest NI) and Highlands and Islands Enterprise (HIE) are to invest up to £2.75m in collaborative feasibility studies to stimulate innovation across four technology areas that will enable and underpin UK growth: advanced materials; biosciences; electronics, sensors and photonics, and information and communications technology (ICT). 

Projects will be led by a small or micro company, in collaboration with one or more business or research partners, with expected costs of £50k to £150k and last from six to 15 months. 

The bioscience proposals should be focused on one or more of the specific elements below: 

Characterisation and discovery tools 

  • commercial application of sequencing technologies focusing on genomics 
  • integration and exploitation of phenotyping technologies 
  • integration of 'omics technologies, such as integrating metabolomic, proteomic, genomic and phenomic data collection and interpretation capabilities 
  • biological imaging systems, biosensors, probes/ markers, diagnostic platforms. 

Production and processing 

  • metabolic engineering 
  • novel manufacturing processes for biological products and novel biological production systems 
  • formulation and delivery approaches for biological products, including biopharmaceuticals and functional foods. 

 Bioinformatics 

  •  approaches to organising, filtering and interpreting biological data, including biological system modelling, data visualisation and user-centred design. 

Projects should be focused on early-stage technical opportunities that: 

  • contain a significant level of technical risk, in that there is some level of uncertainty about how the proposed technical approach will work in practice 
  • involve companies carrying out most (if not all) of the research in-house. Projects should build a technical evidence base to enable progression to larger-scale projects. 

This competition opens on 6 May 2014, and the deadline for applications is noon on 25 June 2014.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Technology Strategy Board Appoints Cell Therapy Catapult CEO
Mr Keith Thompson will be responsible for short and long-term objectives of the Catapult.
Monday, April 30, 2012
New Research will Help make Foods Healthier, Safer and More Nutritious
Over fifty research projects and studies aimed at developing healthier, safer and more nutritious food are to share over £7 million of UK government investment.
Tuesday, October 11, 2011
Funding Agreed for Four Collaborative Research and Development Projects in Industrial Biotechnology
Four projects that will develop and commercialize innovative processes to generate high value chemicals to share £1.5 million of support funding.
Monday, April 18, 2011
New Funding Scheme will Support Innovative Small Companies
Enable companies to research and develop new products, processes and services that could stimulate economic growth.
Tuesday, March 22, 2011
Small Companies to Share £2.5M in new Government Investment to Develop Industrial Biotechnology Processes
The government has announced that it is to invest £2.5 million to stimulate innovation in the UK’s industrial biotechnology sector, with most funding going to small and medium-sized companies.
Friday, March 12, 2010
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!